Beneficial Effect of Oral Lithium Carbonate in the Treatment of Pancreatic Cholera Syndrome
- 19 June 1980
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 302 (25) , 1403-1404
- https://doi.org/10.1056/nejm198006193022507
Abstract
PANCREATIC cholera syndrome is characterized by profuse, watery diarrhea and hypokalemia associated with a non-beta islet-cell neoplasm of the pancreas.1 About half the patients with the syndrome have metastases at diagnosis2; chemotherapy with streptozocin can produce remissions.1 In patients without metastases, the disease may be cured by resection of the tumor.2 Agents such as prednisone3 and indomethacin4 may reduce or abolish the diarrhea.We demonstrate that oral lithium therapy can substantially reduce diarrhea in a patient with pancreatic cholera.Case ReportA 60-year-old woman had had diabetes mellitus and pancreatic cholera syndrome caused by a metastatic non-beta islet-cell carcinoma. . . .Keywords
This publication has 8 references indexed in Scilit:
- Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndromeGastroenterology, 1978
- Indomethacin-Responsive Pancreatic CholeraNew England Journal of Medicine, 1977
- Pancreatic Cholera: Beneficial Effects of Treatment with StreptozotocinNew England Journal of Medicine, 1975
- Vasoactive Intestinal Peptide Stimulation of Adenylate Cyclase and Active Electrolyte Secretion in Intestinal MucosaJournal of Clinical Investigation, 1974
- LithiumAnnual Review of Pharmacology, 1971
- Recognition and management of the diarrheal syndrome caused by nonbeta islet cell tumors of the pancreasThe American Journal of Surgery, 1970
- Islet Cell Tumor of the Pancreas with Reversible Watery Diarrhea and AchlorhydriaGastroenterology, 1967